Back to search

Article

Epitope Engineered Human Haematopoietic Stem Cells are Shielded from CD123-targeted Immunotherapy

2023-07-12

Abstract excerpt

<h4>Summary</h4> Targeted eradication of transformed or otherwise dysregulated cells using monoclonal antibodies (mAb), antibody-drug conjugates (ADC), T cell engagers (TCE) or chimeric antigen receptor (CAR) cells is very effective for haematologic diseases. Unlike the breakthrough progress achieved for B cell malignancies, there is a pressing need to find suitable antigens for immunotherapy of myeloid malignanc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bd7db515-9013-5d34-a1b3-7e75eb9ccdb3
DOI
10.1101/2023.07.11.547391
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Epitope Engineered Human Haematopoietic Stem Cells are Shielded from CD123-targeted ImmunotherapyDOI 10.1101/2023.07.11.547391
Select a neighboring publication to make it the new centre.